Next Generation Joint and Mobility Actives in Food Supplements
Next-generation joint and mobility actives in food supplements are reshaping musculoskeletal health by moving beyond traditional ingredients like glucosamine and chondroitin toward multi-targeted solutions including bioactive collagen peptides, advanced botanical extracts, and microbiome-modulating probiotics. Driven by the rapidly aging population projected, these nutraceuticals aim to support joint comfort, cartilage integrity, and long-term mobility through evidence-based, synergistic mechanisms.
Author: Daria Šurić, Mpharm, univ.spec.
Shifting the Protein Paradigm: Health, Sustainability, and the Rise of Plant-Based Alternatives
Plant-based protein is emerging as a sustainable, high-quality alternative to animal protein, supporting muscle health, weight management, and overall nutrition while significantly reducing environmental impact and greenhouse gas emissions. As demand for sustainable diets grows, plant protein sources such as legumes, soy, and microalgae are reshaping the future of healthy, eco-friendly nutrition.
Author: Lucija Sobotinčić, Msc.Nutrition
BioVivo Science Launches U.S.-Made Natural Caffeine from Green Tea at Natural Products Expo West
BioVivo Science, a supplier and manufacturer of premium, science-driven botanical solutions made in the USA, will debut its natural caffeine ingredient at Natural Products Expo West booth 3743B, offering brands a clean-label, plant-based energy solution sourced exclusively from green tea (Camellia sinensis). BioVivo Science’s natural caffeine provides formulators with a fully traceable, U.S.-manufactured ingredient that […]
Saanroo Appoints Viral Shah as Senior Business Development Director, North America
Saanroo has appointed Viral Shah as Senior Business Development Director, North America, further strengthening its technical and commercial presence across the region.
Saanroo Expands Business Development Presence in Latin America
Saanroo (formerly Gencor) has opened its first office in Latin America – Mexico and expanded its global commercial team by appointing Evelyng Ordaz Santana as Business Development Manager.This expansion reflects Saanroo’s ongoing focus on long-term, regionally grounded growth and deeper collaboration with supplement manufacturers worldwide. Evelyng is a food engineer with more than 20 years […]
GC Rieber VivoMega Launches New Vegan DHA + EPA Algal Oil at NPEW, Expanding its Vegan Omega-3 Portfolio
GC Rieber VivoMega has launched Algae 1045 TG, a high-potency DHA + EPA algal oil that expands its portfolio of sustainable, vegan omega-3 concentrates for plant-based formulations. Produced using proprietary SuperLight™ processing technology, Algae 1045 TG delivers clean-label performance with excellent bioavailability, purity, and sensory quality.
Layn Natural Ingredients Launches NAD at Natural Products Expo West, Expanding Its Cellular Energy and Performance Portfolio
Layn Natural Ingredients, one of the world’s largest manufacturers and innovators of botanical extract solutions, announces the debut of its new Nicotinamide Adenine Dinucleotide (NAD) ingredient at Natural Products Expo West, booth 3743A.
Calling all nutraceutical innovators: Vitafoods Europe Innovation Awards return in 2026
Following a successful first edition in 2025, Informa Markets has announced the return of the Vitafoods Europe Innovation Awards to celebrate the nutraceutical industry’s most exciting and groundbreaking advancements. Serving as a key platform for recognising nutraceutical excellence, the awards will take place during Vitafoods Europe 2026 on 5 May, once again spotlighting the outstanding […]
Be Active in the “Inner Beauty” Movement: Discover VERISOL® byGELITA at in-cosmetics Global 2026
At this year’s in-cosmetics global, GELITA invites visitors to “Be Active!” and experience the science behind Beauty from Within. From April 14 – 16, 2026, in Paris, GELITA will showcase its proven Bioactive Collagen Peptides brand VERISOL® in the new “Inner Beauty” area (Booth 2R140).
Advanced CBD Formulations: Personalized Approaches in Hypertension and Sex-Specific Absorption Insights
This review examines cannabidiol (CBD) as a non-psychotropic cannabinoid with growing clinical and nutraceutical relevance. It highlights regulatory-approved CBD medicines and focuses on novel lipid-based formulations designed to improve oral bioavailability. Results from two randomized crossover studies demonstrate enhanced absorption, sex-dependent pharmacokinetics, and CYP450 genotype – related metabolic differences using a lipophilic CBD formulation. Improved cardiovascular outcomes and minimal adverse effects were observed. The findings emphasize the importance of personalized dosing, advanced delivery systems, and improved professional education on CBD use.
Author: Ana Batinić, M.pharm, PhD in Toxycology